Industry Could Help Asia Establish Adverse Event Monitoring Systems – DIA Conference
This article was originally published in PharmAsia News
As countries like India and China reform their pharmacovigilance systems, opportunities are increasing for improved relationships between international companies and regulatory authorities despite stagnant harmonization efforts
You may also be interested in...
Bristol-Myers Squibb and Accenture have established a center for pharmacovigilance as part of Accenture's Life Sciences Centers of Excellence in Chennai, India, Accenture announced Sept. 13
Australia and New Zealand's plan to establish a joint agency to regulate therapeutic products has been shelved after New Zealand lawmakers failed to support legislation to approve the country's participation in the venture
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).